课题基金 / 基金详情

Retinitis Pigmentosa diagnosis and therapy: retinal remodeling and optogenetic reactivation of degenerated retina

Retinitis Pigmentosa diagnosis and therapy: retinal remodeling and optogenetic reactivation of degenerated retina
色素性视网膜炎的诊断和治疗：视网膜重塑和退化视网膜的光遗传学再激活
批准号：
290147
负责人：
Lachapelle Pierre
金额：
$18.9万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-05-01 至 2016-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=290147&lang=en
关键词：
Blindness Optogenetic Photoreceptor Plasticity Retina Retinitis Pigmentosa Therapy

项目摘要

项目成果

Lachapelle Pierre的其他基金

相似基金

相关文献

中文摘要
翻译
色素性视网膜炎（RP）是一种罕见的遗传性视网膜疾病，导致无法治愈的失明。当大多数光感受器退化并失去对光的反应能力时，大量休眠的锥状光感受器可以持续存在。RP
英文摘要
Retinitis pigmentosa (RP) is a hereditary rare disease of the retina leading to incurable blindness. When most photoreceptors degenerate and lose their ability to respond to light, a substantial quantity of dormant cone photoreceptors can persist. The RP
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnosis, prognosis and classification of retinopathies: Comparing time-amplitude domain (TAD) with time-frequency domain (TFD) analyses of the electroretinogram.
CIHR team on assessment of residual retinal function
海外基金